[VRDN] QoQ Quarter Result on 30-Sep-2014 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
14-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- 50.23%
YoY- -86.02%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 734 645 655 1,301 1,274 1,091 1,091 -23.27%
PBT -2,562 -2,634 -2,258 -1,637 -3,289 -706 -203 444.59%
Tax 0 0 0 0 0 0 0 -
NP -2,562 -2,634 -2,258 -1,637 -3,289 -706 -203 444.59%
Tax Rate - - - - - - - -
Total Cost 3,296 3,279 2,913 2,938 4,563 1,797 1,294 86.82%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin -349.05 -408.37 -345.00 -125.84 -258.25 -64.70 -18.63 609.21%
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
EPS -4.94 -6.82 -5.85 -6.05 -12.14 -2.80 -1.08 176.31%
EPS Diluted -4.94 -6.82 -5.85 -6.05 -12.14 -2.80 -1.08 176.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.